CASE DISCUSSION
Intensive Care Management of liver transplanted patients
Presented India by Dr. Shakti SwaroopViews
15,181
Credit Points
Learning Hours
CPD Points
CME Points
Courses Completed
Case Description
Intensive care management of liver transplanted patients involves close monitoring in the immediate postoperative period to address potential complications and ensure graft function. Careful assessment of vital signs, fluid balance, and laboratory parameters is crucial to detect early signs of...
Case Summary
- The presentation covers intensive care management of liver transplant recipients, focusing on critical care rather than donor aspects. It outlines the three phases of liver transplant: pre-anhepatic (dissection), anhepatic (vascular exclusion), and neo-hepatic (reperfusion). Key terms like cold ischemia time, warm ischemia time, and IVC clamp time are explained, highlighting their implications. Complications are classified into medical (hemodynamic, renal, neurological) and surgical (hemorrhage, vascular problems, biliary issues).
Speaker Profile
Dr. Shakti Swaroop
Senior ConsultantLiver Transplant Anaesthesia & Critical Care AIG hospitals, HyderabadDr. Shakti Swaroop is an experienced Anesthesiologist with an extensive background in anesthesia, critical care, and healthcare consulting. He has worked in leading premium hospitals across India and internationally, with significant experience in JCI-accredited healthcare institutions.
With expertise in Liver Transplant Anaesthesia and Critical Care, Dr. Swaroop has played a key role in managing complex perioperative and critical care cases. He also possesses a strong foundation in Cardiac Anesthesia and has actively contributed to clinical research, medical education, and advanced patient care practices.
Known for his commitment to excellence in healthcare delivery, Dr. Shakti Swaroop continues to contribute to the advancement of anesthesiology and critical care through his vast clinical and academic experience.
Disclosures
Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.